about
cDNA cloning of the immunoglobulin heavy chain binding protein.Virus-neutralizing monoclonal antibody expressed in milk of transgenic mice provides full protection against virus-induced encephalitis.Botulinum neurotoxins and botulism: a novel therapeutic approach.Consequences of receptor editing at the lambda locus: multireactivity and light chain secretion.Birth pangs: the stressful origins of lymphocytes.Expression of immunoglobulin heavy chain at a high level in the absence of a proposed immunoglobulin enhancer element in cis.A theory of allelic and isotypic exclusion for immunoglobulin genesLight chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance.Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus.Light chain replacement: a new model for antibody gene rearrangementSomatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice.Immunoglobulin heavy chain toxicity in plasma cells is neutralized by fusion to pre-B cellsHow antibodies foldAllelic exclusion of immunoglobulin genes: models and mechanisms.Efficient expression from one CMV enhancer controlling two core promoters.Genetically engineered antibody molecules and their application.Prospects for human monoclonal antibodies: a critical perspective.Consequences of frameshift mutations at the immunoglobulin heavy chain locus of the mouse.Derivation and diversification of monoclonal antibodies.Violations of the 12/23 rule at the mouse immunoglobulin kappa locus, including V kappa-V kappa rearrangementAggregates, crystals, gels, and amyloids: intracellular and extracellular phenotypes at the crossroads of immunoglobulin physicochemical property and cell physiology.Production of anti TNF-α antibodies in eukaryotic cells using different combinations of vectors carrying heavy and light chains.Detection of leishmania antigen in kala azar patients using monoclonal antibodies.Hyperosmotic pressure enhances immunoglobulin transcription rates and secretion rates of KR12H-2 transfectoma.
P2860
Q33563900-BB4DDFC2-A635-4C23-BBF0-85FCA7CFDF32Q33865777-63EF7243-7B31-4B65-BB3B-2F448F4B0376Q34070659-31541FCD-5535-46A6-ABC1-F731E8B53597Q34983943-FBFA793F-B20D-49CE-9325-635931C99475Q36029236-92D949E0-1CDE-447D-A55F-25E36AF2342EQ36257612-2CD7010E-5DD4-44FA-8CF4-249D423FF5D7Q36321233-4F76C44F-85AC-49D2-983E-C05B815DAB28Q36364008-B6ED4A3F-86D1-4C39-B24E-CAF148D4E8A1Q36364520-983ACFCD-79CE-49A0-8C53-05C35B46DE11Q36365220-A5ADB5E2-4B24-4856-9201-EA72FF73D0EBQ36375280-A68BCDB1-E4D5-4A2C-95FC-C53E134EBFD9Q37577618-C657DBC2-2A90-41E5-A1D0-2163F99EAF94Q37659557-DD66802C-9B36-4028-A31D-CCD3EF37D123Q37781386-AABC6710-295D-4D03-8AEC-2AA3CB19E7CAQ39626455-33E37A21-0C62-45AC-8E3F-6B8C4755AE7FQ39696556-DB32F3FC-D553-49B2-AF39-74442F1D13EBQ40132669-BD960F55-6C5D-48DE-99BD-8F92F0A16CB4Q41381072-3BDD6E5A-86BC-415D-B264-744CA4829905Q41394586-0EA03CD5-91DD-49A5-AE81-94E9BC0D1CACQ41430029-2B50229F-8086-4420-B083-A3DD6B766DE5Q41831737-B10635CD-ABE9-486F-BB91-7072A6FAB3B6Q42050860-F1AB3C13-100C-4560-8E5D-76B124B9612CQ45299220-0586EC5A-AA26-4F66-AB78-E0672F714627Q52080309-04B90A8A-6F38-4C2E-9959-30252A2BC588
P2860
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh
1980年學術文章
@zh-hant
name
Immunoglobulin chain loss in hybridoma lines.
@ast
Immunoglobulin chain loss in hybridoma lines.
@en
type
label
Immunoglobulin chain loss in hybridoma lines.
@ast
Immunoglobulin chain loss in hybridoma lines.
@en
prefLabel
Immunoglobulin chain loss in hybridoma lines.
@ast
Immunoglobulin chain loss in hybridoma lines.
@en
P2860
P356
P1476
Immunoglobulin chain loss in hybridoma lines.
@en
P2093
P2860
P304
P356
10.1073/PNAS.77.4.2197
P407
P577
1980-04-01T00:00:00Z